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Purpose: To investigate changes in the oxidant-antioxidant system in pterygium tissue.
Methods: Tissue samples ablated from 40 patients during pterygium surgery constituted the study material, while normal
nasal conjunctiva tissue samples from 20 patients matched for age group (who had undergone surgery for strabismus or
extracapsular cataract surgery) were used as controls. The samples were kept at −70 °C until the time of analysis. Catalase
(CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) enzymatic activity and the levels of nitric
oxide (NO) and malone dialdehyde (MDA) were studied in both groups.
Results: The mean age was 54.0±12 years in the pterygium patients and 49.0±19 in the controls (p=0.270). The enzyme
activity levels were significantly lower in the pterygium group when compared to the controls (p<0.001 in each case),
while in the same group a significant increase was observed in the MDA and NO levels (also p<0.001, in both cases).
Conclusions: These findings indicating oxidative stress in the pterygium tissue suggest that oxidative stress can play a
role in pterygium etiopathogenesis.
Pterygium is an epithelial hyperplasia characterized by
the presence of fibro-vascular tissue, thought to be formed by
the advancement of transformed conjunctival tissue into the
cornea  [1].  A  role  of  ultraviolet  (UV)  radiation  damage,
irritation,  or  inflammation  is  hypothesized  in  its
etiopathogenesis;  the  form,  incidence,  and  distribution  of
pterygium support the possible role of UV radiation [2,3]. The
peripheral focus theory [4,5] and the acute and chronic tissular
inflammation that has been demonstrated to be an effect of
UV radiation also support the thesis that such radiation is an
important factor in the pathogenesis of pterygium [6-8].
UV radiation acts directly by phototoxicity or indirectly
through  free  radicals  (FR.)  Intracellularly,  the  FR  cause
oxidative  damage  by  acting  on  macromolecules  such  as
proteins, lipids, and nucleic acids. The FR, which consist
principally  of  molecules  like  the  superoxide  anion  (O2
-),
hydrogen peroxide (H2O2) and peroxynitrite (ONOO-), are
detoxified by enzymes such as superoxide dismutase (SOD),
catalase (CAT), and glutathione peroxidase (GSH-Px.) The
antioxidant system and the amount of FR are kept in a certain
state of homeostasis. When exogenous or endogenous factors
increase oxidative stress, homeostasis is disturbed and the FR
denature  many  basic  intracellular  molecules  like  nucleic
acids, proteins, and lipids. As for malone dialdehyde (MDA),
a  product  of  the  breakdown  into  their  essential  chains  of
mainly  unsaturated  fatty  acids  through  the  oxidation
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mechanism, MDA is accepted as a reliable marker of the lipid
peroxidation that occurs as a result of oxidative stress.
It has been reported in recent times that certain growth
factors,  such  as  the  vascular  endothelial  growth  factor
(VEGF), and cellular mediators like nitric oxide (NO), also
play a role in the pathogenesis of pterygium [9,10]. It is also
stated that NO, primarily secreted by the endothelium and
hypothesized  to  play  a  role  in  vasodilation,
neurotransmission,  and  inflammation,  also  takes  part  in
vascular tonus, vascular permeability, and capillary vessel
growth  [9].  It  has  been  observed  to  act  as  a  protective
antioxidant  agent  at  physiologic  doses,  and  when
administered in large amounts it has oxidating and apoptotic
properties and enhances VEGF production [11,12]. It is also
known that UV radiation increases NO release also by non-
enzymatic  means  [13].  All  these  observations  concur  to
suggest that vasoproliferative processes and their contributing
factors play a role in pterygium pathogenesis.
The presence of oxidative stress and of supporting data
relative to NO does not mean that their role in the genesis of
pterygium is clear yet [14,15]. The objective of our study is
to expose observations on oxidative stress and changes in NO
in both pterygium and the normal conjunctiva and investigate
the role they play in the development of pterygium.
METHODS
Between  January  2005  and  March  2006,  subjects  who
underwent  surgery  for  pterygium  (Group  I),  and  control
subjects (Group II) in matching age groups who had been
operated  on  for  strabismus  or  cataracts  and  in  whom
conjunctiva samples were collected from the nasal limbus
area, were included in the study. Patients who had already
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mology, Ankara, Turkeyundergone eye surgery; those afflicted with ocular diseases
such as glaucoma, uveitis, and dry eye syndrome; those with
systemic  disease  such  as  diabetes  or  rheumatoid  arthritis;
those with chronic addictions including those to smoking and
alcohol; and those with pterygium of the atrophic type were
all excluded from the study. All tissue samples were collected
with the patient's consent and the approval of the Hospital
Ethical  Committee.  Pterygium  surgery  was  performed  by
dissecting  the  pterygium  head  away  from  the  cornea  and
excising it en bloc with the body. During the procedure, the
conjunctiva was dissected and separated as well as possible
from the subconjunctival fibrovascular tissue, aiming to thus
avoid  conjunctival  changes  initiated  by  the  presence  of
subconjunctival tissues. All conjunctiva samples were kept at
−70  °C  until  the  performance  of  the  biochemical
investigations. The MDA and NO levels and the activity of
SOD, CAT, and GSH-Px in the samples were then measured.
MDA  levels  were  measured  by  using  the  reaction
between  MDA  and  Thiobutyric  Acid-Reactive  Substance
(TBARS) at 90–95 °C, which produces a pink chromogen,
followed  15  min  later  by  the  spectrophotometric  reading
at 532 nm of the absorbance in the samples submitted to
accelerated cooling [16].
The  determination  of  NO  levels  were  essentially
performed by the diazotization N-naphthylethylene diamine
(NNDA) dependent on nitrite and sulfanilamide produced by
the Griess reaction and the modified cadmium reaction, and
spectrophotometrically measuring the color produced by this
reaction [17] at 545 nm.
The  measurement  of  SOD  activity  is  based  on  the
reduction  of  nitroblue  tetrazolium  (NBT)  by  superoxide
produced  with  the  xanthine/xanthine  oxidase  system,
following a modified version of the methods used by Sun et
al. [18] and Durak et al. [19]. The absorbance of the resulting
formazone  was  measured  at  560  nm  to  determine  the
enzymatic activity.
GSH-Px activity was measured following the method
communicated  by  Paglia  et  al.  [20].  In  the  presence  of
hydrogen  peroxide,  GSH-Px  catalyzes  the  oxidation  of
reduced glutathione to oxidized glutathione. The reduction in
absorbance during the oxidation of the nicotinamide adenine
dinucleotide phosphate (NADP) used in the reaction to NADP
+  is  measured  to  determine  the  enzymatic  activity.  CAT
activity  was  determined  by  the  Aebi  method  [21],  by
measuring at 240 nm the reduction in absorbance created by
the decomposition (by CAT) of the added hydrogen peroxide
into water and oxygen. The protein level of the supernatant
was determined by Lowry's method [22]; MDA and NO levels
were expressed as nmol/g protein, SOD activity as U/mg
protein, CAT activity as k/g protein, and that of GSH-Px as
U/g protein [21].
The software package SPSS 12.0 (SPSS for Windows,
version  12.0,  SPSS  Inc.,  Chicago,  IL)  was  used  for  all
statistical  analysis.  Student's  t-test  was  used  to  analyze
continuous  variables  and  the  χ2  test  was  used  to  analyze
categorical variables of the groups. A p-value of less than 0.05
was considered statistically significant.
RESULTS
The  demographic  characteristics  of  the  groups  and  the
measured enzymatic activity, and MDA and NO levels are
shown in Table 1 and Table 2, respectively. There was no
significant difference among the two groups as to age or sex
distribution  (Table  1).  An  important  and  statistically
significant reduction in the enzymatic activity levels of SOD,
CAT,  and  GSH-Px  was  observed  in  the  study  group  as
compared to those of the control group (p<0.001 for all three
values.) The NO and MDA values in the study group were
significantly higher than in the control group (p<0.001 for
both).
DISCUSSION
The  etiopathogenesis  of  pterygium  is  controversial.  Even
though there are many publications showing the influence of
UV radiation [23-25], the role of the antioxidant system is still
subject to discussion. We have determined in our study that,
alongside the significant reduction in the enzymatic activity,
there was a significant increase in the NO level. We think that
these findings show the presence of oxidative stress in the
etiology of pterygium and can contribute to earlier reports
relative to NO [14,15].
TABLE 1. DEMOGRAPHIC PROPERTIES OF THE STUDY POPULATION.
Demographic properties Pterygium Control p
Age 54±12.0 48±19.46 0.270¶
Sex     0.232§
Female 26 16  
Male 14 4  
Laterality     0.273§
Right eye 18 11  
Left eye 22 9  
          Values are given as mean±SD (¶: Student t-test; §: χ2).
Molecular Vision 2011; 17:443-447 <http://www.molvis.org/molvis/v17/a50> © 2011 Molecular Vision
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that released by the endothelium and neuronal sources, can
also  be  non-specifically  activated  by  endotoxins  and
cytokines, and as a result that NO can be released in many
different tissues [26,27]. Free oxygen radicals, diverse growth
factors and cytokines, like cyto-oxygenase 2 (COX2), play a
known role in skin cancers developing under the influence of
UV radiation [28-32]. COX2 is a cytokine that plays a notable
part  in  angiogenesis  induced  by  inflammatory  cytokines
[33]. Chiang et al. [34] have shown the presence of COX2 in
pterygial tissue and reported that it might play a role in the
pathogenesis of pterygium. Studies in cornea and pterygium
tissue samples have shown increases in cytokine and growth
factor levels [23]. An increase in NO due to higher cytokine
activity caused by UV radiation seems a possible mechanism;
the  increased  activity  of  inducible  nitric  oxide  synthase
(iNOS) found in pterygium tissue also shows the presence of
an enzymatic infrastructure for the NO increase [15]. Aside
from all this, we should not forget that UV radiation can
directly increase NO expression, by non-enzymatic means
[13].
The  NO  increase  that  we  found  agrees  with  findings
byother authors, especially Lee et al. [15]. The increase in
serum and vitreous humor NO levels observed in diabetes and
age-related macular degeneration, i.e., diseases dominated by
vascular  pathology  and  degeneration,  also  supports  our
findings [35,36]. It seems possible for high levels of NO to be
a factor increasing oxidative stress by means of their oxidating
and apoptotic influence [11,12,37]. Beside these influences,
there  are  also  studies  showing  that  NO  participates  in
angiogenesis. It was observed that angiogenesis induced by
VEGF can be slowed in vivo by NO synthetase inhibition
[38]. Papapetropoulos et al. [11] reported that NO participates
in  the  angiogenic  activity  of  VEGF.  The  observation  by
Marcovici et al. [10] of excessive quantities of VEGF in the
pterygium tissue also indicates the presence of angiogenesis
in  the  development  of  pterygium.  Considering  also  that
prostaglandin E1 (PGE1) and substance-P (SP) also contribute
to angiogenic response [38,39], there are many factors which
could contribute to the increase in NO level in pterygium.
While supporting the findings by Lee et al. [15] (increased
iNOS), our study results are different than those reported by
Özdemir et al. [14]. In contradiction to thesis that a low NO
level could be related to the fact that NO is depleted by use as
a protective agent against oxidative stress, and that it also
could be a result of the use of the entire pterygial tissue instead
of epithelium use only, Solomon [40] proposed that this fact
might be the result of hyper-irrigation of the blood by the rich
vascular net of the pterygium. This is the opposite of the
ischemic conditions [35,36] through which NO levels rise.
The results obtained by Özdemir et al. [14] could also have
been due to clinical variables, like the condition, atrophic or
not, of the pterygia that had undergone surgery. We selected
cases  of  non-atrophic,  vascularized  and  inflammatory
pterygium of the progressive type. The active angiogenesis in
such cases could be one cause for our findings of high levels
of  NO.  Information  on  the  clinical  appearance  of  the
pterygium cases is not found in the report by Özdemir et al.
[14]. Additionally, in our samples, we dissected away the
subepithelial parts developing from the Tenon capsule to as
great an extent possible, to keep them as similar as possible
to  the  control  samples.  Our  aim  in  this  was  to  avoid
contamination  of  our  results  by  subconjunctival  tissues
subject to abnormal fibro-elastotic transformation. However,
such a hypothesis remains to be tested, and a comparison of
levels of VEGF and NO in pterygium samples that include or
lack  subconjunctival  tissue  must  still  be  performed  in
advanced studies. One other possible reason for finding high
NO levels in pterygium cases could be that NO is produced in
excess as a protector against the oxidative stress related to UV
radiation or chronic inflammation.
We observed other powerful indications, in our study, of
the  presence  of  oxidative  stress  in  pterygium  tissue.  The
oxidative stress showed itself in the increased level of MDA
and the reduced activity of the enzymes SOD, CAT, and GSH-
Px.
The  fall  in  antioxidant  enzyme  activities  could  be
correlated  to  the  detoxification  of  the  possibly  increased
number of oxidative stress molecules. It has been shown in
many  degenerative  processes  that  changes  in  antioxidant
enzyme activities accompany an increase in lipid peroxidation
[41-43]. Also, in other experimental works, UV damage has
TABLE 2. SOD, CAT, GSH-PX ACTIVITIES AND MDA, NO LEVELS.
Enzymes Pterygium Control p
SOD (U/mg protein) 0.0210±0.0051 0.0446±0.0073 0.000¶
CAT (k/g protein) 0.0890±0.0328 0.4382±0.0996 0.000¶
GSH-Px (U/g protein) 0.9255±0.2038 2.8360±0.4797 0.000¶
MDA (nmol/g protein) 12.2078±1.7552 7.7482±0.2681 0.000¶
NO (μmol/g protein) 0.7586±0.0538 0.0353±0.0037 0.000¶
        Values are given as mean±SD (¶: Student t-test; SOD: Superoxide dismutase; CAT: Catalase; GSH-Px: Glutathione peroxidase;
        MDA: Malondialdehyde; NO: Nitric oxide.)
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eye [44,45] and in other tissues [46], in correlation with a fall
in  antioxidant  enzymatic  activity  and  an  increase  in  lipid
peroxidation. The presence of oxidative stress in pterygium
has  been  proved  by  finding  an  increase  in  8-OHdG  (8-
hydroxydeoxyguanosine)  [24].  The  significant  increase
(p<0.001) in MDA, consistently accompanying significant
decreases (p<0.001) in the activity of SOD, CAT, and GSH-
Px in our study, leads us to think that oxidative stress is an
important mechanism in the development of pterygium.
In this study, we evaluated NO, the antioxidant system
enzymes, and lipid peroxidation together for the first time. Our
results  show  that  oxidative  stress  plays  a  role  in  the
etiopathogenesis of pterygium. We cannot forget, however,
that as much as UV radiation is an important factor in the
pathogenesis of oxidative stress, chronic inflammation also
plays a part in the development of this lesion, and oxidative
stress can increase with inflammation. To conclude, oxidative
stress and NO do play a role in the development of pterygium,
and  this  complex  process  must  be  kept  in  mind  in  the
prevention and treatment of pterygium.
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